HUT63827A - Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same - Google Patents

Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same

Info

Publication number
HUT63827A
HUT63827A HU9202515A HU251592A HUT63827A HU T63827 A HUT63827 A HU T63827A HU 9202515 A HU9202515 A HU 9202515A HU 251592 A HU251592 A HU 251592A HU T63827 A HUT63827 A HU T63827A
Authority
HU
Hungary
Prior art keywords
producing
same
pharmaceutical compositions
sulfonanilide
sulfonanilide derivatives
Prior art date
Application number
HU9202515A
Other languages
English (en)
Other versions
HU9202515D0 (en
Inventor
Akira Morino
Iwao Morita
Shin-Ichi Tada
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of HU9202515D0 publication Critical patent/HU9202515D0/hu
Publication of HUT63827A publication Critical patent/HUT63827A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
HU9202515A 1990-02-07 1991-02-06 Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same HUT63827A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2767590 1990-02-07
JP13636090 1990-05-25
JP27804190 1990-10-16
PCT/JP1991/000138 WO1991012236A1 (fr) 1990-02-07 1991-02-06 Derive de sulfonanilide et medicament

Publications (2)

Publication Number Publication Date
HU9202515D0 HU9202515D0 (en) 1992-10-28
HUT63827A true HUT63827A (en) 1993-10-28

Family

ID=27285908

Family Applications (3)

Application Number Title Priority Date Filing Date
HU9202515A HUT63827A (en) 1990-02-07 1991-02-06 Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same
HU95P/P00207P HU00207A9 (en) 1990-02-07 1995-06-15 Sulfonanilide derivatives and medicine
HU95P/P00551P HU211578A9 (en) 1990-02-07 1995-06-29 3-(2-amino-1-hydroxyethyl)-4-fluoro-methane sulphonanilide and pharmaceutical uses thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU95P/P00207P HU00207A9 (en) 1990-02-07 1995-06-15 Sulfonanilide derivatives and medicine
HU95P/P00551P HU211578A9 (en) 1990-02-07 1995-06-29 3-(2-amino-1-hydroxyethyl)-4-fluoro-methane sulphonanilide and pharmaceutical uses thereof

Country Status (14)

Country Link
EP (1) EP0538469B1 (hu)
JP (1) JPH0819084B2 (hu)
KR (1) KR0150649B1 (hu)
CN (1) CN1043526C (hu)
AT (1) ATE128459T1 (hu)
AU (1) AU637197B2 (hu)
BR (1) BR9105995A (hu)
CA (1) CA2075482C (hu)
DE (1) DE69113466T2 (hu)
DK (1) DK0538469T3 (hu)
ES (1) ES2078507T3 (hu)
GR (1) GR3018226T3 (hu)
HU (3) HUT63827A (hu)
WO (1) WO1991012236A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
DE4447389A1 (de) * 1994-12-22 1996-06-27 Schering Ag Disubstituierte p-Fluorbenzolsulfonamide
FR2737494B1 (fr) 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2768055A1 (fr) 1997-09-11 1999-03-12 Synthelabo Utilisation de derives de sulfonanilide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
ATE291907T1 (de) * 1998-10-20 2005-04-15 Omeros Corp Spülende lösung und methoden zur hemmung von schmerzen und entzündungen
CA2365503A1 (en) * 1999-04-01 2000-10-12 Koki Matsubara Method for the preparation of tricyclic amino alcohol derivatives through azides
WO2001040173A1 (fr) * 1999-11-29 2001-06-07 Nippon Shinyaku Co., Ltd. Procede de separation et de purification
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
US6660772B2 (en) 2001-02-01 2003-12-09 Boehringer Ingelheim Pharma Kg Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
CN102234237B (zh) * 2010-04-22 2014-03-26 赤峰艾克制药科技股份有限公司 L-苯福林盐酸盐的制备方法
CN101863847B (zh) * 2010-07-02 2012-01-11 浙江省诸暨合力化学对外贸易有限公司 一种磺酰苯胺类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3566886D1 (en) * 1984-05-04 1989-01-26 Upjohn Co N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides

Also Published As

Publication number Publication date
EP0538469A1 (en) 1993-04-28
AU7213891A (en) 1991-09-03
ES2078507T3 (es) 1995-12-16
DE69113466T2 (de) 1996-03-14
KR0150649B1 (ko) 1998-10-15
WO1991012236A1 (fr) 1991-08-22
EP0538469B1 (en) 1995-09-27
JPH0819084B2 (ja) 1996-02-28
HU9202515D0 (en) 1992-10-28
DE69113466D1 (de) 1995-11-02
HU211578A9 (en) 1995-12-28
CN1054249A (zh) 1991-09-04
DK0538469T3 (da) 1996-01-15
KR927003525A (ko) 1992-12-18
HU00207A9 (en) 1995-09-28
ATE128459T1 (de) 1995-10-15
GR3018226T3 (en) 1996-02-29
CA2075482C (en) 1999-08-31
EP0538469A4 (en) 1992-09-28
AU637197B2 (en) 1993-05-20
BR9105995A (pt) 1992-11-17
CN1043526C (zh) 1999-06-02

Similar Documents

Publication Publication Date Title
HUT72317A (en) Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence
HUT63827A (en) Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same
AU7815791A (en) Heterocyclene derivatives
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
HUT75111A (en) Use of pyridyl-,oxadiazole or thiadiazole derivatives for producing pharmaceutical compositions having effect
AU8163294A (en) Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
WO1999057125A3 (en) Hygromycin a derivatives
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
GR3007079T3 (hu)
TW222622B (hu)
HU9203052D0 (en) Method for treatment of hypertension
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
HK1012007A1 (en) Bile acid sulfurated derivatives
HUT49849A (en) Process for producing ketenedithioacetal derivatives and pharmaceutical compositions comprising these compounds as active ingredient
DE59008807D1 (de) Imidazolylpropylguanidinderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel.
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina
MY130671A (en) Substituted benzopyran derivatives for the treatment of inflammation
MY120772A (en) Substituted benzopyran derivatives for the treatment of inflammation

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal
DFD9 Temporary protection cancelled due to non-payment of fee